Les Funtleyder is a longtime health care investor who started his professional investing career just over two decades ago. Today, he is a health care portfolio manager at E Squared Capital Management in New York. He’s also an author of the book called “Health Care Investing.” He was in Boston recently to give a guest lecture at Tufts University and he stopped by STAT’s offices for a chat about the current and future state of health care investing.
We want you to compare and contrast biotech investing today versus when you started on Wall Street. The science, of course, has gotten a lot more complex. So how do you adapt?